pfizer profit - Search News

News

Pfizer Raises Profit Outlook

The Wall Street Journal on MSN · 18h

Pfizer Raises Profit Outlook Despite Uncertainty Over Tariffs, Drug Prices

Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.

Reuters on MSN · 1d

Pfizer raises 2025 profit forecast as cost-cutting program gains traction

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday. CEO Albert Bourla also said the company has been in active discussions with members of the U.

MarketWatch on MSN · 1d

Pfizer boosts profit estimate, even as tariffs are absorbed and drug prices may be cut

Pfizer increased its 2025 profit outlook by 10 cents a share to a range of $2.90 a share to $3.10 a share, citing continued cost cuts, a lower tax rate and “confidence” that strength seen in the first half of the year will continue.

Pfizer Pops Despite Looming Pharma Tariffs

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...

GlobalData on MSN1d

Pfizer shares rise 3% after upping profit forecast for 2025

Pfizer bucked the trend of a tepid big pharma Q2 window, raising its full-year profit forecast on the back of strong sales ...

14h

Stocks to Watch Recap: Palantir, Coinbase, Gartner, Pfizer

Shares in the data-software company were up 7.8% Tuesday after it posted higher quarterly results and [boosted its annual ...

Free Malaysia Today on MSN1d

Pfizer profits boosted by Covid-19 products, lower expenses

Pfizer reported a jump in second quarter profits Tuesday behind higher sales of Covid 19 products and some other ...

Pfizer lifts annual profit outlook as Q2 results come ahead, shares gain

Pfizer said the revised profit outlook reflects strong results in the first half of the year, improved cost efficiency, a ...

New York Post3y

Pfizer Q1 profit, revenue soar on COVID-19 vaccine sales

Pfizer’s stock hit an all-time high price of $61.71 on Dec. 20. But that price has fallen 18% so far this year, a steeper drop than the roughly 13% decline of the Standard & Poor’s 500 index.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results